Precision medicine at Blue Latitude Health
|7th November 2019
Many stakeholders are confused by precision medicines, including patients and healthcare professionals. So, how can industry help them to navigate this complexity? At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video below to get a run down on three core components to consider when commercialising these innovative products.
Our content has moved
|18th November 2020
We’re posting all new articles on our parent website fishawack.com
Fishawack Health launches Delta Magazine
|17th November 2020
Our parent company Fishawack Health has launched a new magazine with a first issue unpacking rare disease.
In the precision medicine era, the line between products and services is blurred
|27th August 2020
Precision and personalised medicines are more than products, they are services in their own right. So, how should pharma approach this uncharted territory to ensure targeted therapies work for patients?